Todd Harris - 15 Sep 2026 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Reporting relationship
President and CEO, Director
Issuer ticker
TYRA
Reported as of
15 Sep 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Sep 2026, 19:29:28 UTC
Prior SEC filing
07 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ali D. Fawaz, Attorney-in-Fact

Key filing fact

Todd Harris filed Form 4 for Tyra Biosciences, Inc. (TYRA) on 17 Sep 2026.

Key facts

  • This page summarizes Todd Harris's Form 4 filing for Tyra Biosciences, Inc. (TYRA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Sep 2026, 19:29.

Change

  • Previous filing in this sequence was filed on 07 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001711463 Primary reporting owner

Harris Todd

Relationship
President and CEO, Director
Address
C/O TYRA BIOSCIENCES, INC., 2656 STATE STREET, CARLSBAD
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Signature date
17 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TYRA transaction

Common Stock

Award

Transaction value
Shares
+864
Change %
+0.06%
Price
$9.13*
Shares after
1,438,495
Date
15 Sep 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.

Footnote F2

Includes restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .